CompletedNot Applicable

Evaluation of Therapeutic Initiative's Cystitis Portrait and Therapeutics Letter

Canada5,073 participantsStarted 2021-09-23

Plain-language summary

The goal of this randomized trial is to test the impact of mailing personalized prescribing Portraits (an audit and feedback tool) and Therapeutics Letters (a reference document) to physicians on first-line prescribing to patients with uncomplicated urinary tract infection (UTI) . The main question this study aims to answer is: • To what extent can personal prescribing feedback Portraits and Therapeutics Letters have an effect on how physicians prescribe antibiotics for uncomplicated UTI? Approximately 5,000 British Columbian Family Practitioners (FP's) have been randomly divided into three groups, and each group received the Portrait at different times. To help ascertain the possible impact of Portraits, pooled data on first-line prescribing for uncomplicated UTI by FP's who received the Portrait at an early time point (September 23, 2021) will be compared to that of those who received a Portrait at a delayed time point (March 28, 2022). Researchers will compare prescribing data from these groups to see if the prescribing Portraits have had a differential impact on prescribing of antibiotics for uncomplicated UTI.

Who can participate

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: Physicians who are: i. Registered with the College of Physicians and Surgeons of B.C. (CPSBC) ii. Defined as a General Practitioner or Family Practice - Emergency Medicine according to the B.C. Ministry of Health's Medical Services Plan (MSP) with a license status of private practice, temporary license, salaried, or post graduate. iii. Hold a valid mailing address in B.C according to the College of Physicians and Surgeons of British Columbia's public physician information. iv. Had \>=100 prescriptions filled at a community pharmacy in 2020 according to PharmaNet claims. v. Diagnosed \>= 1 eligible patient with Uncomplicated Acute Cystitis (UAC) in 2019 or 2020 (for delay group: 2020 to 2021 Exclusion Criteria: Non-physicians, or physicians who: i. Were not registered with the College of Physicians and Surgeons of B.C. (CPSBC) ii. Were not classified as a General Practitioner or Family Practice - Emergency Medicine according to the B.C. Ministry of Health's Medical Services Plan (MSP) with a license status of private practice, temporary license, salaried, or post graduate. iii. Had an invalid mailing address in B.C according to the College of Physicians and Surgeons of British Columbia's public physician information. iv. Had \<=100 prescriptions filled at a community pharmacy in 2020 according to PharmaNet claims. v. Diagnosed \<= 1 eligible patient with Uncomplicated Acute Cystitis (UAC) in 2019 or 2020 (for delay group: 2020 to 2021

What they're measuring

Monthly prescribing of Nitrofurantoin

Timeframe: The study period for the primary analysis is the 185 day period after the early intervention, which is from September 24, 2021 to March 28, 2022..

Trial details

NCT IDNCT05817253

SponsorUniversity of British Columbia

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2022-09-28

View on ClinicalTrials.gov More Clinical Audit trials

Plain-language summary

Who can participate

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.